Crinetics Cash from 2010 to 2025

CRNX Stock

USD 37.35 0.87 2.38%

Crinetics Pharmaceuticals Cash yearly trend continues to be fairly stable with very little volatility. Cash is likely to outpace its year average in 2025. Cash is the total amount of money in the form of currency that Crinetics Pharmaceuticals has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals

Cash

First Reported

2016-12-31

Previous Quarter

302.2 M

Current Value

317.3 M

Quarterly Volatility

96.3 M

Covid

Check Crinetics Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Crinetics Pharmaceuticals' main balance sheet or income statement drivers, such as Net Interest Income of 16.2 M, Interest Income of 16.2 M or Depreciation And Amortization of 760.2 K, as well as many indicators such as Price To Sales Ratio of 918, Dividend Yield of 0.0 or PTB Ratio of 3.62. Crinetics financial statements analysis is a perfect complement when working with Crinetics Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Crinetics Pharmaceuticals Correlation against competitors.

For more information on how to buy Crinetics Stock please use our How to Invest in Crinetics Pharmaceuticals guide.

Latest Crinetics Pharmaceuticals' Cash Growth Pattern

Below is the plot of the Cash of Crinetics Pharmaceuticals over the last few years. Cash refers to the most liquid asset of Crinetics Pharmaceuticals, which is listed under current asset account on Crinetics Pharmaceuticals balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Crinetics Pharmaceuticals customers. The amounts must be unrestricted with restricted cash listed in a different Crinetics Pharmaceuticals account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Crinetics Pharmaceuticals' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Crinetics Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

Cash

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Cash

Timeline

Crinetics Cash Regression Statistics

	Arithmetic Mean	43,551,514
	Geometric Mean	28,020,668
	Coefficient Of Variation	112.71
	Mean Deviation	32,907,643
	Median	32,672,000
	Standard Deviation	49,086,017
	Sample Variance	2409.4T
	Range	188.5M
	R-Value	0.57
	Mean Square Error	1744.6T
	R-Squared	0.32
	Significance	0.02
	Slope	5,870,453
	Total Sum of Squares	36141.6T

Crinetics Cash History

	2025	67.8 M
	2024	63.1 M
	2023	54.9 M
	2022	32.7 M
	2021	200.7 M
	2020	93.1 M
	2019	40.3 M

Other Fundumenentals of Crinetics Pharmaceuticals

	Cash And Short Term Investments
	Change In Cash
	Free Cash Flow
	Begin Period Cash Flow

Crinetics Pharmaceuticals Cash component correlations

	Change In Cash	Free Cash Flow	Begin Period Cash Flow	End Period Cash Flow	Free Cash Flow Yield	Free Cash Flow Per Share	Cash Per Share	Ev To Free Cash Flow	Cash Ratio	Cash Conversion Cycle	Price Cash Flow Ratio	Cash Flow To Debt Ratio
Change In Cash		-0.02	-0.53	0.59	0.0	-0.16	0.24	0.13	0.2	0.51	0.12	0.63
Free Cash Flow	-0.02		-0.52	-0.51	0.77	0.94	-0.64	-0.78	0.86	-0.13	-0.79	-0.28
Begin Period Cash Flow	-0.53	-0.52		0.37	-0.63	-0.47	0.32	0.54	-0.51	-0.11	0.55	-0.59
End Period Cash Flow	0.59	-0.51	0.37		-0.6	-0.6	0.59	0.66	-0.25	0.46	0.65	0.11
Free Cash Flow Yield	0.0	0.77	-0.63	-0.6		0.84	-0.65	-0.92	0.76	-0.5	-0.92	-0.11
Free Cash Flow Per Share	-0.16	0.94	-0.47	-0.6	0.84		-0.75	-0.89	0.89	-0.21	-0.9	-0.41
Cash Per Share	0.24	-0.64	0.32	0.59	-0.65	-0.75		0.82	-0.72	0.15	0.81	0.32
Ev To Free Cash Flow	0.13	-0.78	0.54	0.66	-0.92	-0.89	0.82		-0.79	0.32	1.0	0.3
Cash Ratio	0.2	0.86	-0.51	-0.25	0.76	0.89	-0.72	-0.79		0.02	-0.8	-0.27
Cash Conversion Cycle	0.51	-0.13	-0.11	0.46	-0.5	-0.21	0.15	0.32	0.02		0.31	0.24
Price Cash Flow Ratio	0.12	-0.79	0.55	0.65	-0.92	-0.9	0.81	1.0	-0.8	0.31		0.3
Cash Flow To Debt Ratio	0.63	-0.28	-0.59	0.11	-0.11	-0.41	0.32	0.3	-0.27	0.24	0.3

Click cells to compare fundamentals

About Crinetics Pharmaceuticals Financial Statements

Crinetics Pharmaceuticals investors use historical fundamental indicators, such as Crinetics Pharmaceuticals' Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Crinetics Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Cash	63.1 M	67.8 M
Cash And Short Term Investments	642.3 M	674.5 M
Change In Cash	20 M	21 M
Free Cash Flow	-153.9 M	-146.2 M
Begin Period Cash Flow	39.1 M	63.1 M
Total Cashflows From Investing Activities	-156.6 M	-148.8 M
Other Cashflows From Financing Activities	17.9 M	21 M
Other Non Cash Items	30.6 M	32.2 M
Total Cash From Operating Activities	-149.7 M	-142.2 M
Total Cash From Financing Activities	447.3 M	469.6 M
End Period Cash Flow	64.6 M	68.4 M
Cash And Cash Equivalents Changes	60.7 M	63.7 M
Cash Flows Other Operating	-1.9 M	-2 M
Other Cashflows From Investing Activities	-176.2 M	-167.3 M
Free Cash Flow Yield	(0.10)	(0.10)
Operating Cash Flow Per Share	(3.29)	(3.46)
Free Cash Flow Per Share	(3.39)	(3.56)
Cash Per Share	8.66	5.06
Capex To Operating Cash Flow	(0.03)	(0.03)
EV To Operating Cash Flow	(11.16)	(11.72)
EV To Free Cash Flow	(10.86)	(11.40)
Price To Operating Cash Flows Ratio	(11.18)	(11.74)
Price To Free Cash Flows Ratio	(10.87)	(11.42)
Cash Ratio	1.44	1.36
Cash Conversion Cycle	765.46	925.23
Operating Cash Flow Sales Ratio	(47.66)	(50.04)
Free Cash Flow Operating Cash Flow Ratio	1.18	1.12
Cash Flow Coverage Ratios	(3.70)	(3.88)
Price Cash Flow Ratio	(11.18)	(11.74)
Cash Flow To Debt Ratio	(3.70)	(3.88)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Additional Tools for Crinetics Stock Analysis

When running Crinetics Pharmaceuticals' price analysis, check to measure Crinetics Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crinetics Pharmaceuticals is operating at the current time. Most of Crinetics Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Crinetics Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crinetics Pharmaceuticals' price. Additionally, you may evaluate how the addition of Crinetics Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Crinetics Cash from 2010 to 2025

Latest Crinetics Pharmaceuticals' Cash Growth Pattern

Crinetics Cash Regression Statistics

Crinetics Cash History

Other Fundumenentals of Crinetics Pharmaceuticals

Crinetics Pharmaceuticals Cash component correlations

About Crinetics Pharmaceuticals Financial Statements

Also Currently Popular

Additional Tools for Crinetics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY